Company / Inventory per Share
Neurocrine Biosciences Inventory per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory per Share
$0.69
FY2025
5-year range
$0.33 / $0.69
FY2021-FY2025
Trend
+19.4%
vs FY2024
Sector context
#46 of 108
Health Care
What the data says
At $0.69, Neurocrine Biosciences's inventory per share ranks #46 of 108 in the Health Care sector. Inventory per Share has increased for 8 consecutive years, from $0.01 in FY2017 to $0.69 in FY2025.
Based on SEC 10-K filings.
0.69 in FY2025 with a 5-year CAGR of +18.0%.
Improved from $0.40 to $0.69 over the past 2 years.
Health Care sector context is included.
Inventory per Share over time
Growth rates
- 3-Year CAGR
- +23.4%
- 5-Year CAGR
- +18.0%
- 10-Year CAGR
- -
Sector benchmark
#46 of 108 in Health CareTop 43% of 108This company $0.69 Sector average $30.00
▼
-97.7% below sector average
Key checks
Key Insights
- Neurocrine Biosciences's inventory per share has grown for 8 consecutive years.
- In FY2025, inventory per share increased 19.4% year-over-year.
- Ranks #46 out of 108 companies in the Health Care sector.
- Lowest inventory per share in the period was in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Inventory per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.69 | +19.4% |
| FY2024 | $0.58 | +46.5% |
| FY2023 | $0.40 | +7.3% |
| FY2022 | $0.37 | +13.4% |
| FY2021 | $0.33 | +7.5% |
| FY2020 | $0.30 | +59.2% |
| FY2019 | $0.19 | +55.7% |
| FY2018 | $0.12 | +938.1% |
| FY2017 | $0.01 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026